Log in
Enquire now
‌

US Patent 11618789 Clinical assessment of M-protein response in multiple myeloma

Patent 11618789 was granted and assigned to MorphoSys on April, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
MorphoSys
MorphoSys
0
Current Assignee
MorphoSys
MorphoSys
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
116187890
Patent Inventor Names
Stefan Härtle0
Date of Patent
April 4, 2023
0
Patent Application Number
160808700
Date Filed
March 3, 2017
0
Patent Primary Examiner
‌
Michael Allen
0
CPC Code
‌
G01N 33/53
0
‌
C07K 16/30
0

Applicant discloses an anti-idiotypic antibody to MOR202, which when fused to human albumin, shifted the anti-body in IFE thus mitigating any potential interference of MOR202 with the M-protein clinical assessment.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11618789 Clinical assessment of M-protein response in multiple myeloma

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.